Automating Anthem (Elevance Health) Infusion Therapy Prior Authorization

Klivira streamlines **Anthem (Elevance Health) Infusion Therapy prior authorization**, addressing the complexities of medical necessity, site-of-service requirements, and multi-channel submissions.

Infusion therapy, often involving high-cost specialty drugs, presents significant prior authorization challenges for revenue cycle teams. Navigating Anthem's specific medical policies and submission channels across their diverse lines of business is critical for timely approvals and minimizing denials.

Navigating Anthem's Infusion Therapy Prior Authorization Landscape

Infusion therapy, encompassing procedures like CPT codes 96360-96379 and various J-codes for specialty drugs, requires meticulous prior authorization (PA) with Anthem. A primary focus for Anthem (Elevance Health) is the site-of-service review, evaluating whether home, outpatient, or in-office settings meet medical necessity. Klivira helps manage the complexities of both medical and pharmacy benefit infusions.

Streamlining Infusion Therapy PA Submissions to Anthem

**Medical Benefit PA:** Submitted via Availity Essentials, Anthem's primary multi-payer provider workspace, supporting PA initiation, benefit lookup, and document upload.
**X12 278 Transactions:** Accepted for medical-benefit infusion procedures through clearinghouses, offering a standardized electronic submission pathway.
**Pharmacy Benefit PA:** Handled by CarelonRx (Elevance Health's PBM), with electronic submissions facilitated through ePA partners like CoverMyMeds and Surescripts.
**Carelon Medical Benefits Management:** For specific specialty drug categories, some infusion-related services may route through Carelon MBM's dedicated portal, requiring verification of current domain scope.

Understanding Anthem's Medical Necessity and Site-of-Service Criteria

Anthem operating companies publish comprehensive medical policies and clinical utilization management guidelines accessible via provider sites through Availity. These policies, which may be Anthem-developed, Carelon-developed, MCG-based, or NCCN-compendium-based, heavily scrutinize the medical necessity and appropriate site of service for infusion therapy. Robust clinical documentation, including diagnostic imaging where relevant to the underlying condition, is essential.

Common Denial Patterns and Appeals for Infusion Therapy with Anthem

Frequent denial reasons for Anthem Infusion Therapy PAs include medical necessity not met, insufficient documentation, and crucially, site-of-service mismatches. Denials are communicated via X12 277/835 transactions and Availity status updates. Klivira supports the structured appeal pathway, which typically follows the Anthem operating company's process, with a separate Carelon-managed pathway for procedures under their scope, and peer-to-peer review options available for both.

Klivira's Approach to Anthem Infusion Therapy PA Automation

Klivira integrates directly with EMR systems and payer portals like Availity to automate the submission and tracking of Anthem Infusion Therapy prior authorizations. Our platform interprets payer-specific guidelines, proactively identifies documentation requirements, and facilitates electronic submission via X12 278 or ePA channels, reducing manual effort and accelerating decision times.

Frequently asked questions

How does Anthem determine the appropriate site of service for infusion therapy?

Anthem's medical policies, accessible through provider portals via Availity, outline specific criteria for site-of-service review. This evaluation considers the patient's clinical stability, drug administration complexity, and safety requirements to determine if home, outpatient, or hospital settings are medically appropriate, often leading to site-of-service mismatch denials if not aligned.

What are the primary channels for submitting Infusion Therapy PA requests to Anthem?

For medical benefit infusions, requests are primarily submitted through Availity Essentials or via X12 278 transactions. For pharmacy benefit infusions managed by CarelonRx, electronic prior authorization (ePA) is available through platforms like CoverMyMeds and Surescripts.

Which criteria does Anthem use for medical necessity review of infusion drugs?

Anthem operating companies utilize a combination of criteria, which can include Anthem-developed guidelines, Carelon-developed criteria for specific categories, MCG (Milliman Care Guidelines), or NCCN (National Comprehensive Cancer Network) compendium for oncology-related infusions. The specific criteria are typically cited within the relevant medical policy on their provider sites.

Are expedited prior authorizations available for Anthem Infusion Therapy requests?

Yes, expedited prior authorizations are available for urgent clinical situations. For Anthem's Medicare Advantage and Medicaid managed care plans, CMS-0057-F mandates specific 24-hour expedited decision timeframes. Commercial plans are governed by state-specific regulations, which also typically include provisions for expedited reviews.

What are common reasons for Anthem Infusion Therapy PA denials?

Common denial reasons include insufficient documentation to support medical necessity, failure to meet clinical criteria, and site-of-service mismatches where the requested location for infusion does not align with Anthem's policy. Additionally, issues related to step therapy requirements or non-formulary drugs can lead to pharmacy benefit denials.